Skip to content

The CCT6A paradigm: biomarker potential and therapeutic challenges in oncology and beyond

Sep 2026 · Molecular Biology Reports · Vol 53 · 0 citations · 83 references
Medicine

TL;DR

This review delineates CCT6A’s multifunctional roles in oncogenesis and immune-metabolic dysregulation, critically evaluates its biomarker potential, and proposes targeted therapeutic frameworks to refine precision medicine paradigms across diverse disease landscapes.

View source

Similar papers

Review Open access Sep 2026

The Role of Mitochondrial Dysfunction in Hepatocellular Carcinoma: From Pathogenesis and Drug Resistance to Targeted Therapeutic Strategies

Abstract Hepatocellular carcinoma (HCC) is characterized by high malignancy and widespread drug resistance at advanced stages, posing formidable challenges in clinical diagnosis and treatment. Mitochondrial dysfunction is a core driver of HCC initiation and drug resistance. However, how its plasticity dynamically regul...

Si-Yu Zhao, Qian Liu, Jing Li et al. · 0 citations
Review Open access Sep 2026

Ribosomal protein S3: a critical regulator of human disease mechanisms

Abstract Ribosomal protein S3 (RPS3) is an essential structural component of the 40S ribosomal subunit, yet growing evidence highlights crucial extraribosomal roles in genome maintenance, cell-cycle control, and immune signaling. Dysregulation of RPS3 contributes to diverse human disorders, including cancer, inflammato...

Joeline Dreik, M. Al Ali, Jalil Daher et al. · 0 citations
Review Oct 2026

RIPK1 kinase and scaffold activities in tumor cell fate and therapy.

Receptor-interacting protein kinase 1 (RIPK1) plays a pivotal role in regulating cell survival and death, thereby exerting complex and multifaceted functions in the initiation and progression of cancer. Its expression is frequently dysregulated across diverse malignancies and correlates strongly with poor prognosis, hi...

Jing-Yu Luo, Shu-Ya Song, Ze-Kun Li et al. · 0 citations
Review Oct 2026

Mechanistic Role of eIF4E in the Hallmarks of Cancer: A Translational Control Perspective.

Cancer progression is driven by coordinated dysregulation of signaling and gene-expression programs that sustain multiple hallmarks of malignancy. Eukaryotic initiation factor 4E (eIF4E) has emerged as an important determinant of this translational reprogramming by preferentially enhancing the synthesis of proteins tha...

Magdalene Eno Udobi, P. Effiong, Sumon Roy et al. · 0 citations
Review Open access Aug 2026

TXNL1 in redox and protein quality control: mechanisms and disease relevance

TXNL1 (thioredoxin-like protein 1), a member of the thioredoxin superfamily, integrates thioredoxin oxidoreductase activity with molecular chaperone function. Through its N-terminal TRX domain and C-terminal PITH domain, TXNL1 not only helps maintain cellular redox homeostasis but also prevents toxic aggregation of oxi...

Shan-Shan Wu, De-Yuan Li, Dong-Qiong Xiao · 0 citations
Review Aug 2026

Squalene Epoxidase in Cancer: Mechanistic Insights, Therapeutic Potential, and Future Perspectives.

This review examines the emerging role of SQLE as a potential metabolic-immune checkpoint, systematically integrating cutting-edge epitranscriptomic regulatory mechanisms published from 2024 to 2026, dissecting the full spectrum of SQLE-mediated immunosuppressive pathways, and conducting critical comparative analysis b...

Qing-Xin Zhang, Chunhui Zhang, Da-Bin Liu · 0 citations

Related blog posts

Google DeepMind Blog Sep 30, 2026

Introducing SynthID Bio

Proof of concept for watermarking AI-generated proteins while preserving biological function.

MIT News · Artificial Intelligence Aug 27, 2026

Looking beyond natural sequences

A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.